← FDA DRUG APPROVALS

FDA NDA · NDA019647

POTASSIUM CITRATE

Sponsor: UT SW MEDCTR

APPLICATION
NDA019647
TYPE
NDA
ORIGINAL APPROVAL
1988-10-13
LATEST ACTION
1988-10-13
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

POTASSIUM CITRATE · ReferenceDiscontinued
POTASSIUM CITRATE 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · FOR SOLUTION · ORAL
POTASSIUM CITRATE · ReferenceDiscontinued
POTASSIUM CITRATE 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · FOR SOLUTION · ORAL

Approval history

1988-10-13Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →